NEOVEL

Description

Composition:  Sevelamer Carbonate (active ingredient).

Product Type: Oral medication in tablet form.

Quantity: 30 tablets per pack.

Strength/Dosage: 800 mg per tablet.

Dosage: As prescribed by a healthcare professional, typically taken with meals.

Indications:
Hyperphosphatemia in Chronic Kidney Disease (CKD): Used to manage high phosphate levels in patients with CKD on dialysis.
Phosphate Binding: Reduces dietary phosphate absorption by binding to phosphate in the gastrointestinal tract.
Prevention of Vascular Calcification: Helps reduce the risk of calcification in blood vessels and soft tissues.
Adjunct Therapy in Renal Care: Supports dietary phosphate restriction and dialysis in managing phosphorus levels.
Improves Quality of Life in CKD Patients: Reduces complications associated with elevated phosphate levels, such as bone disorders and itching.